Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress

Clinical Cancer Research

Volumn 11, Issue 9, 2005, Pages 3175-3183

  Baldi, Alfonso ^a,d   Lombardi, Daniela ^e   Russo, Patrizia ^a   Palescandolo, Emanuele ^a   De Luca, Antonio ^a   Santini, Daniele ^b   Baldi, Feliciano ^d   Rossiello, Luigi ^d   Dell'Anna, Maria Lucia ^c   Mastrofrancesco, Arianna ^c   Maresca, Vittoria ^c   Flori, Enrica ^c   Natali, Pier Giorgio ^a   Picardo, Mauro ^c   Paggi, Marco G ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; FERRITIN; POLYUNSATURATED FATTY ACID; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL GROWTH; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOMA; METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL LINE; TUMOR GROWTH; TUMOR VOLUME; VALIDATION PROCESS;

ANIMALS; APOPTOSIS; CATALASE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, ANTISENSE; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FATTY ACIDS, UNSATURATED; FERRITINS; GENE EXPRESSION; HUMANS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION; VITAMIN E;

EID: 20944435524     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0631     Document Type: Article

References (73)

1. Newton Bishop JA. Molecular pathology of melanoma. Cancer Metastasis Rev 1997;16:141-54.
2. Welch DR, Goldberg SF. Molecular mechanisms controlling human melanoma progression and metastasis. Pathobiology 1997;65:311-30.
3. Nyormoi O, Bar-Eli M. Transcriptional regulation of metastasis-related genes in human melanoma. Clin Exp Metastasis 2003;20:251-63.
4. van Groningen JJ, Bloemers HP, Swart GW. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display. Cancer Res 1995;55:6237-43.
5. Hashimoto Y, Shindo-Okada N, Tani M, Takeuchi K, Toma H, Yokota J. Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. Cancer Res 1996;56:5266-71.
6. Simon HG, Risse B, Jost M, Oppenheimer S, Kari C, Rodeck U. Identification of differentially expressed messenger RNAs in human melanocytes and melanoma cells. Cancer Res 1996;56:3112-7.
7. Ishiguro T, Nakajima M, Naito M, Muto T, Tsuruo T. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res 1996;56:875-9.
8. Duncan LM, Deeds J, Hunter J, et al. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res 1998; 58:1515-20.
9. Zendman AJ, Cornelissen IM, Weidle UH, Ruiter DJ, van Muijen GN. TM7XN1, a novel human EGF-TM7-like cDNA, detected with mRNA differential display using human melanoma cell lines with different metastatic potential. FEBS Lett 1999;446:292-8.
10. Huang F, Adelman J, Jiang HP, Goldstein NI, Fisher PB. Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells. Oncogene 1999;18:3546-52.
11. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000;406:532-5.
12. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000;406:536-40.
13. Leonetti C, Biroccio A, Candiloro A, et al. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin. Clin Cancer Res 1999;5:2588-95.
14. Baldi A, Battista T, De Luca A, et al. Identification of genes down-regulated during melanoma progression: a cDNA array study. Exp Dermatol 2003;12:213-8.
15. Le NT, Richardson DR. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 2002;1603:31-46.
16. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002;99:3505-16.
17. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996;1275:161-203.
18. Boyd D, Vecoli C, Belcher DM, Jain SK, Drysdale JW. Structural and functional relationships of human ferritin H and L chains deduced from cDNA clones. J Biol Chem 1985;260:11755-61.
19. Bomford AB, Munro HN. Ferritin gene expression in health and malignancy. Pathobiology 1992;60:10-8.
20. Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 1996;93:8175-82.
21. Vaughn CB, Weinstein R, Bond B, et al. Ferritin content in human cancerous and noncancerous colonic tissue. Cancer Invest 1987;5:7-10.
22. Guner G, Kirkali G, Yenisey C, Tore IR. Cytosol and serum ferritin in breast carcinoma. Cancer Lett 1992; 67:103-12.
23. Weinstein RE, Bond BH, Silberberg BK. Tissue ferritin concentration in carcinoma of the breast. Cancer 1982;50:2406-9.
24. Cohen C, Shulman G, Budgeon LR. Immunohistochemical ferritin in testicular seminoma. Cancer 1984; 54:2190-4.
25. Meyskens FL Jr, McNulty SE, Buckmeier JA, et al. Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes. Free Radic Biol Med 2001;31:799-808.
26. Kwok JC, Richardson DR. The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Crit Rev Oncol Hematol 2002;42:65-78.
27. Richardson DR. The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell. Eur J Biochem 2000;267:1290-8.
28. Food MR, Des RR. Iron uptake by melanoma cells from the soluble form of the transferrin homologue, melanotransferrin. Redox Rep 2002;7:279-82.
29. Baldi A, De Luca A, Claudio PP, et al. The Rb2/p130 gene product is a nuclear protein whose phosphorylation is cell cycle regulated. J Cell Biochem 1995;59:402-8.
30. Lombardi D, Palescandolo E, Giordano A, Paggi MG, Interplay between the antimetastatic nm23 and the retinoblastoma-related Rb2/p130 genes in promoting neuronal differentiation of PC12 cells. Cell Death Differ 2001;8:470-6.
31. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-45.
32. Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989;179:8-18.
33. Clairborne A. Catalase activity. In: Greenwald RA, editor. Handbook of methods for oxygen radical research. Boca Raton (FL): CRC; 1985. p. 283-4.
34. Burton GW, Webb A, Ingold KU. A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratios. Lipids 1985;20:29-39.
35. Picardo M, Grammatico P, Roccella F, et al. Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. J Invest Dermatol 1996;107:322-6.
36. Jentzsch AM, Bachmann H, Furst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996;20:251-6.
37. Passi S, Morrone A, De Luca C, Picardo M, Ippolito F. Blood levels of vitamin E, polyunsaturated fatty acids of phospholipids, lipoperoxides and glutathione peroxidase in patients affected with seborrheic dermatitis. J Dermatol Sci 1991;2:171-8.
38. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
39. Luzzago A, Arosio P, Iacobello C, et al. Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies. Biochim Biophys Acta 1986;872:61-71.
40. Francanzani AL, Fargion S, Romano R, et al. Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis. Gastroenterology 1989;96:1071-8.
41. Garrone P, Neidnardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 1995;182:1265-73.
42. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
43. Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 1997;57:3823-9.
44. Ariza ME, Broome-Powell M, Lahti JM, Kidd VJ, Nelson MA. Fas-induced apoptosis in human malignant melanoma cell lines is associated with the activation of the p34(cdc2)-related PITSLRE protein kinases. J Biol Chem 1999;274:28505-13.
45. Chow CK. Vitamin E and oxidative stress. Free Radic Biol Med 1991;11:215-32.
46. Sheridan AM, Fitzpatrick S, Wang C, Wheeler DC, Lieberthal W. Lipid peroxidation contributes to hydrogen peroxide induced cytotoxicity in renal epithelial cells. Kidney Int 1996;49:88-93.
47. Kulp KS, Green SL, Vulliet PR. Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells. Exp Cell Res 1996;229:60-8.
48. Hileti D, Panayiotidis P, Hoffbrand AV. Iron chelators induce apoptosis in proliferating cells. Br J Haematol 1995;89:181-7.
49. Leardi A, Caraglia M, Selleri C, et al. Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells. Br J Haematol 1998;102:746-52.
50. Meyskens FL Jr, Farmer P, Fruehauf JP. Redox regulation in human melanocytes and melanoma. Pigment Cell Res 2001;14:148-54.
51. Cen D, Gonzalez RI, Buckmeier JA, Kahlon RS, Tohidian NB, Meyskens FL Jr. Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Mol Cancer Ther 2002;1:197-204.
52. Rossiello R, Carriero MV, Giordano GG. Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue. J Clin Pathol 1984;37:51-5.
53. Fleming S. Immunocytochemical localization of ferritin in the kidney and renal tumours. Eur Urol 1987;13:407-11.
54. Carter RL, Hall JM, Corbett RP. Immunohistochemical staining for ferritin in neuroblastomas. Histopathology 1991;18:465-8.
55. Yang HB, Hsu PI, Lee JC, Chan SH, Lin XZ, Chow NH. Adenoma-carcinoma sequence: a reappraisal with immunohistochemical expression of ferritin. J Surg Oncol 1995;60:35-40.
56. Weber A, Engers R, Nockemann S, Gohr LL, Zur HA, Gabbert HE. Differentially expressed genes in association with in vitro invasiveness of human epithelioid sarcoma. Mol Pathol 2001;54:324-30.
57. Hazard JT, Drysdale JW. Ferritinaemia in cancer. Nature 1977;265:755-6.
58. Luger TA, Linkesch W, Knobler R, Kokoschka EM. Serial determination of serum ferritin levels in patients with malignant melanoma. Oncology 1983;40:263-7.
59. Kikyo N, Suda M, Kikyo N, et al. Purification and characterization of a cell growth factor from a human leukemia cell line: immunological identity with ferritin. Cancer Res 1994;54:268-71.
60. Gray CP, Franco AV, Arosio P, Hersey P. Immunosuppressive effects of melanoma-derived heavy-chain ferritin are dependent on stimulation of IL-10 production. Int J Cancer 2001;92:843-50.
61. Chedekel MR. Photochemistry and photobiology of epidermal melanins. Photochem Photobiol 1982;35: 881-5.
62. Meyskens FL Jr, Buckmeier JA, McNulty SE, Tohidian NB. Activation of nuclear factor-κB in human metastatic melanoma cells and the effect of oxidative stress. Clin Cancer Res 1999;5:1197-202.
63. Pham CG, Bubici C, Zazzeroni F, et al. Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell 2004;119:529-42.
64. Rohrdanz E, Schmuck G, Ohler S, Tran-Thi QH, Kahl R. Changes in antioxidant enzyme expression in response to hydrogen peroxide in rat astroglial cells. Arch Toxicol 2001;75:150-8.
65. Meewes C, Poswig A, Dissemond J, Brenneisen P, Scharffetter-Kochanek K. Adaptive antioxidant defence in human dermal fibroblasts. Br J Dermatol 2000;143:662-3.
66. Meewes C, Brenneisen P, Wenk J, et al. Adaptive antioxidant response protects dermal fibroblasts from UVA-induced phototoxicity. Free Radic Biol Med 2001;30:238-47.
67. 2. Biol Chem 2001;382:1697-705.
68. Yohn JJ, Norris DA, Yrastorza DG, et al. Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes, and melanocytes. J Invest Dermatol 1991;97:405-9.
69. Gutteridge JM. Biological origin of free radicals, and mechanisms of antioxidant protection. Chem Biol Interact 1994;91:133-40.
70. Minotti G, Aust SD. The role of iron in oxygen radical mediated lipid peroxidation. Chem Biol Interact 1989; 71:1-19.
71. Maresca V, Roccella M, Roccella F, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997;109:310-3.
72. Kwok JC, Richardson DR. Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: inhibition of the ferritin iron mobilization pathway. Mol Pharmacol 2003;63:849-61.
73. Weeraratna AT, Becker D, Carr KM, et al. Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome. Oncogene 2004;23: 2264-74.